XBP1s in breast cancer cells has been shown to drive malignant progression by promoting tumor cell survival and metastasis under hypoxic conditions9,10, and previously, we reported that aberrant IRE1α-XBP1 signaling in intratumoral leukocytes facilitated immune escape and metastasis in ovarian cancer11,12. Here, ERN1 is linked to breast carcinoma.